How to overcome the excess ASCVD risk conferred by Lp(a)? - PACE-CME

How to overcome the excess ASCVD risk conferred by Lpa

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Findings of analysis on pediatric FH patients in large global registry
Findings of analysis on pediatric FH patients in large global registry
EAS 2022
Findings of analysis on pediatric FH patients in large global registry
New oral therapy of CETP inhibition for lipid lowering
New oral therapy of CETP inhibition for lipid lowering
EAS 2022
New oral therapy of CETP inhibition for lipid lowering
- Prof Kausik Ray
What is the role of imaging and how can it guide medical therapy in ASCVD?
What is the role of imaging and how can it guide medical therapy in ASCVD?
EAS 2022
What is the role of imaging and how can it guide medical therapy in ASCVD?
- Prof. Stephen Nicholls, MD
Welcome to the EAS 2022 congress
Welcome to the EAS 2022 congress
EAS 2022
Welcome to the EAS 2022 congress
- Prof Kausik Ray